Fig. 7: The level of DNAI2 in lung cancer patients. | Cell Death & Disease

Fig. 7: The level of DNAI2 in lung cancer patients.

From: PTEN decreases NR2F1 expression to inhibit ciliogenesis during EGFRL858R-induced lung cancer progression

Fig. 7

The level of DNAI2 in the early and late stages of lung cancer in the indicated cohorts was evaluated by IHC staining with an anti-DNAI2 antibodies A. Working model: PTEN inhibits NR2F1 expression to decrease bronchial cell hyperplasia during EGFRL858R-induced lung cancer progression but does not have this effect on alveolar cells B.

Back to article page